Home
Versant Venture Capital VI reported a 3.4% stake in Monte Rosa Therapeutics GLUE · 2,236,708 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 3.4%
- Last report
- 5.1% · filed 25/11/12
- Shares held
- 2,236,708 sh
- Class
- Common Stock, par value $0.0001 per share
- Event date
- 26/01/07
- Filed
- 26/01/09
3.4% stake · below 5%
- Stake
- 3.4%
- Last report
- 5.1%
- Since last report
- −1.7pp
Monte Rosa Therapeutics trades, last 26 weeks
What else happened in Monte Rosa Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/08~02/06Versant Venture Capital VI's other 5% stake reports
- Versant Venture Capital VI
5% stakeTempest Therapeutics
5% stakeTempest Therapeutics
TPST
1.1% stake
162,972 sh
1.1% stake
Filed 04/02
- Versant Venture Capital VI
5% stakeMonte Rosa Therapeutics
5% stakeMonte Rosa Therapeutics
GLUE
5.1% stake
3,334,669 sh
5.1% stake
Filed 25/11/12
- Versant Venture Capital VI
5% stakeLenz Therapeutics
5% stakeLenz Therapeutics
LENZ
3.4% stake
1,050,599 sh
3.4% stake
Filed 25/11/10
- Versant Venture Capital VI
5% stakeLenz Therapeutics
5% stakeLenz Therapeutics
LENZ
4.1% stake
1,183,543 sh
4.1% stake
Filed 25/09/22
- Versant Venture Capital VI
5% stakeLenz Therapeutics
5% stakeLenz Therapeutics
LENZ
4.9% stake
1,400,220 sh
4.9% stake
Filed 25/08/20
